Free Trial

SelectQuote, Inc. (NYSE:SLQT) Shares Sold by Los Angeles Capital Management LLC

SelectQuote logo with Finance background
Remove Ads

Los Angeles Capital Management LLC lowered its position in SelectQuote, Inc. (NYSE:SLQT - Free Report) by 16.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 313,740 shares of the company's stock after selling 59,900 shares during the period. Los Angeles Capital Management LLC owned approximately 0.18% of SelectQuote worth $1,167,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. Rhumbline Advisers boosted its stake in shares of SelectQuote by 2.6% in the fourth quarter. Rhumbline Advisers now owns 209,743 shares of the company's stock worth $780,000 after buying an additional 5,235 shares during the last quarter. SG Americas Securities LLC boosted its stake in shares of SelectQuote by 10.5% during the 4th quarter. SG Americas Securities LLC now owns 91,508 shares of the company's stock worth $340,000 after acquiring an additional 8,660 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of SelectQuote by 36.9% in the third quarter. JPMorgan Chase & Co. now owns 429,656 shares of the company's stock valued at $932,000 after buying an additional 115,865 shares in the last quarter. Virtu Financial LLC acquired a new position in SelectQuote during the third quarter worth $150,000. Finally, Barclays PLC lifted its holdings in SelectQuote by 166.8% during the third quarter. Barclays PLC now owns 198,357 shares of the company's stock valued at $430,000 after purchasing an additional 124,005 shares in the last quarter. 34.59% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

SelectQuote Price Performance

SLQT traded down $0.03 on Wednesday, reaching $4.00. 1,359,797 shares of the company's stock were exchanged, compared to its average volume of 1,250,086. SelectQuote, Inc. has a twelve month low of $1.48 and a twelve month high of $6.86. The stock has a market cap of $687.72 million, a PE ratio of -44.39 and a beta of 1.13. The company has a debt-to-equity ratio of 2.10, a current ratio of 6.36 and a quick ratio of 6.36. The stock's fifty day moving average price is $4.46 and its 200-day moving average price is $3.30.

SelectQuote (NYSE:SLQT - Get Free Report) last posted its quarterly earnings results on Monday, February 10th. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.21. SelectQuote had a negative return on equity of 4.38% and a negative net margin of 0.95%. Sell-side analysts expect that SelectQuote, Inc. will post -0.07 EPS for the current year.

Analyst Ratings Changes

A number of analysts have recently commented on SLQT shares. Royal Bank of Canada restated a "sector perform" rating and set a $4.00 price target on shares of SelectQuote in a research report on Friday, November 22nd. Noble Financial raised SelectQuote to a "strong-buy" rating in a research note on Wednesday, February 12th.

Check Out Our Latest Report on SelectQuote

Insider Activity

In other SelectQuote news, insider Sarah Taylor Anderson sold 50,000 shares of SelectQuote stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $5.44, for a total transaction of $272,000.00. Following the completion of the sale, the insider now directly owns 1,166 shares in the company, valued at $6,343.04. This trade represents a 97.72 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 11.40% of the company's stock.

SelectQuote Profile

(Free Report)

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.

See Also

Institutional Ownership by Quarter for SelectQuote (NYSE:SLQT)

Should You Invest $1,000 in SelectQuote Right Now?

Before you consider SelectQuote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.

While SelectQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

3 AI Stocks to Watch After NVIDIA’s Dip

3 AI Stocks to Watch After NVIDIA’s Dip

NVIDIA may be down, but the AI boom isn’t slowing anytime soon! While investors react to short-term price swings, smart money is looking at three stocks that could benefit from NVIDIA’s continued domi

Related Videos

7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads